Jenburkt Pharmaceuticals Ltd — Insider Trading, 18-06-2026: Insider Trading / SAST

Jenburkt Pharmaceuticals has announced the closure of its trading window for designated persons, insiders, and their relatives. The window will be closed from July 1, 2026, ahead of the upcoming financial results for the quarter. It will reopen 48 hours after these results are made public. The company plans to announce the Board Meeting schedule to consider these results separately. This ensures fair information disclosure and prevents insider trading before key financial updates.